Tampa General Hospital is getting a serious financial jolt. Ian and Jean MacKechnie are putting $10 million toward a new immunotherapy research lab and helping fuel one of the hospital’s biggest construction projects in years.
The Ian & Jean MacKechnie Immunotherapy Lab is planned at roughly 8,000 square feet inside the USF Health building in downtown Tampa, where it will sit within the TGH Cancer Institute. Hospital leaders say part of the MacKechnies’ gift will also support the Taneja Surgical, Neuroscience & Transplant Tower that is currently rising on Davis Islands.
The Tampa General Hospital Foundation is calling the donation transformational and says the lab is designed to speed up translational immunology work that aims to “arm the immune system” against cancer and other diseases, according to Tampa General Hospital. The lab will sit in the Tampa Medical & Research District and spotlight the health system’s academic partnership with the University of South Florida. Tampa General first outlined the gift in early March as part of a broader push to grow its research footprint.
What the Lab Will Study
In the new space, researchers are expected to zero in on cellular therapies and immune-based strategies that could be used across different tumor types and other diseases. “We have made amazing strides in the ability to target cancer with immunotherapy,” Dr. Ivan Borrello said, adding that the MacKechnies’ support will help pave the pathway to new cellular therapies and translational research, per Tampa Bay Business & Wealth. Hospital officials describe the lab as a bridge between bench science and treatments available to patients in the region.
A Gift Born From Personal Care
The MacKechnies say their donation grew out of personal experience. Ian MacKechnie received care at Tampa General, where he was treated by Dr. Jorge Marcet, and the family points to the hospital team’s work as a key motivation for the gift, according to local reporting. John Couris, TGH president and CEO, has framed the donation as both a bet on academic medicine and a way to shore up regional access to advanced care, as covered by St. Pete Catalyst. Both donors and hospital leaders have stressed that the money is meant to boost research and deliver concrete benefits at the bedside.
Accreditation and Academic Ties
Tampa General notes that the gift lands at a time when its immunotherapy and cellular-therapy programs have secured accreditation from the Foundation for the Accreditation of Cellular Therapy, or FACT. That designation is a marker of clinical standards in stem cell transplant and cell therapies and is recognized by regulatory and professional organizations, according to Tampa General Hospital. TGH’s status as USF Health’s primary teaching hospital is central to the downtown lab plan, and leaders say close academic ties should help draw investigators and clinical trials to Tampa.
Why This Matters Now
The foundation announced the MacKechnie gift in March, but the story resurfaced in local coverage in May as outlets highlighted how the donation fits alongside the under-construction Taneja tower and the broader growth of Tampa’s medical research district, per West Orlando News. Locating the lab downtown is intended to deepen collaboration with USF Health while keeping advanced research and potential clinical trials within reach for patients across the region. Hospital officials say the new facility is expected to shorten the time from lab discovery to clinic and to expand local clinical options.
Ian MacKechnie is the founder of Amscot Financial, and the company’s site underscores his role and the firm’s long-standing presence in Tampa. The MacKechnies have supported other Florida causes as well. The couple previously donated $1 million to the American Red Cross after major hurricanes, according to a company release published via PR Newswire, and hospital leaders say this latest, larger investment is intended to accelerate discovery while expanding clinical capacity in Tampa Bay.
